<DOC>
	<DOCNO>NCT00299013</DOCNO>
	<brief_summary>The purpose study investigate whether novel dosage form prednisolone ester , call COLAL-PRED® , useful treatment ulcerative colitis .</brief_summary>
	<brief_title>Study COLAL-PRED® Treatment Moderate Acute Ulcerative Colitis</brief_title>
	<detailed_description>Ulcerative colitis disease cause inflammation large bowel , cause fever , diarrhoea , dehydration symptom . Standard treatment ulcerative colitis include general medical treatment fluid salt replacement attention diet . Anti-inflammatory medicine steroid ( e.g . prednisolone ) aminosalicylates ( e.g . mesalazine ) main drug treatment . This study investigate whether COLAL-PRED® , novel dosage form prednisolone ester , safe effective treatment ulcerative colitis , compare standard treatment ( conventional prednisolone ) also determine dose work best future patient .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Endoscopically confirm diagnosis ulcerative colitis Score 610 Disease Activity Index ( DAI ) Moderate severe mucosal appearance Previous colonic surgery Other treatment ulcerative colitis stabilise Clinically significant diabetes , heart failure , unstable angina , cirrhosis , renal failure History tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Ulcerative colitis</keyword>
</DOC>